BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22619192)

  • 1. Bisphosphonates in the treatment of osteoporosis.
    Poole KE; Compston JE
    BMJ; 2012 May; 344():e3211. PubMed ID: 22619192
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw is becoming more common.
    Loukota RA
    BMJ; 2012 Sep; 345():e5988; author reply e5990. PubMed ID: 22963942
    [No Abstract]   [Full Text] [Related]  

  • 3. Review overemphasises benefits and downplays serious harms.
    Musini V; Mintzes B; Tejani A; Wright JM
    BMJ; 2012 Sep; 345():e5989; author reply e5990. PubMed ID: 22963943
    [No Abstract]   [Full Text] [Related]  

  • 4. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
    Yamada S; Inaba M; Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():348-51. PubMed ID: 18161129
    [No Abstract]   [Full Text] [Related]  

  • 6. Undertreatment after hip fracture: a retrospective study of osteoporosis overlooked.
    Davis JC; Ashe MC; Guy P; Khan KM
    J Am Geriatr Soc; 2006 Jun; 54(6):1019-20. PubMed ID: 16776813
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing the next "bone event".
    Adler RA
    J Am Geriatr Soc; 2010 Apr; 58(4):762-4. PubMed ID: 20398160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone quality].
    Ito M
    Nihon Rinsho; 2009 May; 67(5):921-5. PubMed ID: 19432110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How soon after hip fracture surgery should a patient start bisphosphonates?
    Seton M
    Cleve Clin J Med; 2010 Nov; 77(11):751-5. PubMed ID: 21048049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmaceutical treatment for patients with hip fracture].
    Hagino H
    Clin Calcium; 2010 Sep; 20(9):1394-400. PubMed ID: 20808048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient's page. Bone health facts.
    McKinney J
    South Med J; 2005 Oct; 98(10):1058. PubMed ID: 16295830
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary prophylaxis of osteoporotic fractures in an orthogeriatric service.
    Kenealy H; Paul S; Walker K; Garg A
    Australas J Ageing; 2011 Mar; 30(1):41. PubMed ID: 21395941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 14. Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women.
    Hsiao FY; Huang WF; Chen YM; Wen YW; Kao YH; Chen LK; Tsai YW
    Clin Ther; 2011 Nov; 33(11):1659-67. PubMed ID: 22018450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
    MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinic effect of alendronate sodium treatment in osteoporosis patients with hip fracture].
    Qiu GX; Wu ZH; Shen JX; Luo XZ; Tang H; Wang YP; Weng XS; Yang XY; Lin J; Jin J; Zhao H; Tian Y; Zhang JG
    Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(6):347-50. PubMed ID: 15144688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meta-analysis of alendronate preventing hip fracture risk of postmenopausal women].
    Yuan T; Li XL; Zhang CQ; Shi HP; Zeng BF
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1620-2. PubMed ID: 19957509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis.
    Martinó A; Rosa J; Guzmán J; Ramírez M
    P R Health Sci J; 2005 Jun; 24(2):131-5. PubMed ID: 16116930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.